Chewable DGL

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

Glycyrrhiza glabra, Quantity: 400 mg (Equivalent: Glycyrrhiza glabra, Qty 4 g)

Tilgjengelig fra:

Factors Group Australia Pty Ltd

Legemiddelform:

Tablet, chewable

Sammensetning:

Excipient Ingredients: silicon dioxide; magnesium stearate; stearic acid; Aniseed Powder; microcrystalline cellulose; xylitol; Stevia rebaudiana

Administreringsrute:

Oral

Indikasjoner:

Anti-inflammatory/relieve inflammation ; Demulcent/soothe irritated tissues ; Decrease/reduce/relieve abdominal pain/discomfort ; Decrease/reduce/relieve symptoms of heartburn ; Helps decrease/reduce/relieve mild gastrointestinal tract inflammation ; Expectorant/clear respiratory tract mucous ; Loosen respiratory tract mucous ; Decrease/reduce/relieve throat mucous membrane irritation/inflammation

Produkt oppsummering:

Visual Identification: ;

Autorisasjon status:

Listed

Autorisasjon dato:

2019-07-31